A multistage chronobiologic intervention for the treatment of depression: A pilot studyMOSCOVICI, Lucian; KOTLER, Moshe.Journal of affective disorders. 2009, Vol 116, Num 3, pp 201-207, issn 0165-0327, 7 p.Article

APOBEC3 Cytidine Deaminases in Double-Strand DNA Break Repair and Cancer PromotionNOWARSKI, Roni; KOTLER, Moshe.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 12, pp 3494-3498, issn 0008-5472, 5 p.Article

The Vif protein of human immunodeficiency virus type 1 (HIV-1): Enigmas and solutionsBARAZ, Lea; KOTLER, Moshe.Current medicinal chemistry. 2004, Vol 11, Num 2, pp 221-231, issn 0929-8673, 11 p.Article

Serum vitamin B₆ in schizophrenic and schizoaffective patients with and without tardive dyskinesiaMIODOWNIK, Chanoch; LERNER, Vladimir; COHEN, Hagit et al.Clinical neuropharmacology. 2000, Vol 23, Num 4, pp 212-215, issn 0362-5664Article

Characterization of a novel virus causing a lethal disease in carp and koiILOUZE, Maya; DISHON, Arnon; KOTLER, Moshe et al.Microbiology and molecular biology reviews. 2006, Vol 70, Num 1, issn 1092-2172, 147-156, b [32 p.]Article

Persistence of cyprinid herpesvirus 3 in infected cultured carp cellsDISHON, Arnon; DAVIDOVICH, Maya; ILOUZE, Maya et al.Journal of virology. 2007, Vol 81, Num 9, pp 4828-4836, issn 0022-538X, 9 p.Article

Anger, impulsivity, social support, and suicide risk in patients with posttraumatic stress disorderKOTLER, Moshe; IANCU, Iulian; EFRONI, Ravit et al.The Journal of nervous and mental disease. 2001, Vol 189, Num 3, pp 162-167, issn 0022-3018Article

Antibody response and resistance of Cyprinus carpio immunized with cyprinid herpes virus 3 (CyHV-3)PERELBERG, Ayana; ILOUZE, Maya; KOTLER, Moshe et al.Vaccine. 2008, Vol 26, Num 29-30, pp 3750-3756, issn 0264-410X, 7 p.Article

Protection of cultured Cyprinus carpio against a lethal viral disease by an attenuated virus vaccinePERELBERG, Ayana; RONEN, Ariel; HUTORAN, Marina et al.Vaccine. 2005, Vol 23, Num 26, pp 3396-3403, issn 0264-410X, 8 p.Article

Association of autonomic dysfunction and clozapine Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medicationCOHEN, Hagit; LOEWENTHAL, U. R. I; MATAR, Michael et al.British journal of psychiatry (Print). 2001, Vol 179, Num AOU, pp 167-171, issn 0007-1250Article

Anxiety and depression in patients with allergic and non-allergic cutaneous disordersPONAROVSKY, Baruch; AMITAL, Daniela; LAZAROV, Aneta et al.International journal of dermatology. 2011, Vol 50, Num 10, pp 1217-1222, issn 0011-9059, 6 p.Article

The Positive and Negative Symptoms Questionnaire: A self-report scale in schizophreniaIANCU, Iulian; POREH, Amir; LEHMAN, Benny et al.Comprehensive psychiatry. 2005, Vol 46, Num 1, pp 61-66, issn 0010-440X, 6 p.Article

Treatment of eating disorders improves eating symptoms but not alexithymia and dissociation pronenessIANCU, Iulian; COHEN, Etti; BEN YEHUDA, Yoram et al.Comprehensive psychiatry. 2006, Vol 47, Num 3, pp 189-193, issn 0010-440X, 5 p.Article

Reduced language lateralization in first-episode schizophrenia: An fMRI index of functional asymmetryBLEICH-COHEN, Maya; HENDLER, Talma; KOTLER, Moshe et al.Psychiatry research. Neuroimaging. 2009, Vol 171, Num 2, pp 82-93, issn 0925-4927, 12 p.Article

Kleptomania: Comorbid psychiatric diagnosis in patients and their familiesDANNON, Pinhas N; LOWENGRUB, Katherine M; IANCU, Iulian et al.Psychopathology. 2004, Vol 37, Num 2, pp 76-80, issn 0254-4962, 5 p.Article

Reversal of pathologic cardiac parameters after transition from clozapine to olanzapine treatment : A case reportCOHEN, Hagit; LOEWENTHAL, Uri; MATAR, Michael A et al.Clinical neuropharmacology. 2001, Vol 24, Num 2, pp 106-108, issn 0362-5664Article

Sulpiride augmentation of olanzapine in the management of treatment-resistant chronic schizophrenia: evidence for improvement of mood symptomatologyKOTLER, Moshe; STROUS, Rael D; REZNIK, Ilya et al.International clinical psychopharmacology. 2004, Vol 19, Num 1, pp 23-26, issn 0268-1315, 4 p.Article

Impulsivity, Aggression and Suicide Risk among Male Schizophrenia PatientsIANCU, Lulian; BODNER, Ehud; ROITMAN, Suzana et al.Psychopathology. 2010, Vol 43, Num 4, pp 223-229, issn 0254-4962, 7 p.Article

Prevalence of self-reported specific phobia symptoms in an israeli sample of young conscriptsIANCU, Iulian; LEVIN, Jennifer; DANNON, Pinhas N et al.Journal of anxiety disorders. 2007, Vol 21, Num 5, pp 762-769, issn 0887-6185, 8 p.Article

Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily livingMENDELSOHN, Erika; ROSENTHAL, Michal; BOHIRI, Yosef et al.International clinical psychopharmacology. 2004, Vol 19, Num 6, pp 319-324, issn 0268-1315, 6 p.Article

Sodium dodecyl sulphate-treated proteins as ligands in ELISALECHTZIER, Valeria; HUTORAN, Marina; LEVY, Talia et al.Journal of immunological methods. 2002, Vol 270, Num 1, pp 19-26, issn 0022-1759, 8 p.Article

Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?KERTZMAN, Semion; VAINDER, Michael; REZNIK, Ilya et al.International clinical psychopharmacology. 2012, Vol 27, Num 3, pp 134-141, issn 0268-1315, 8 p.Article

Never resting region — mPFC in schizophreniaBLEICH-COHEN, Maya; KUPCHIK, Marina; GRUBERGER, Michal et al.Schizophrenia research. 2012, Vol 140, Num 1-3, pp 155-158, issn 0920-9964, 4 p.Article

Risk-taking decisions in pathological gamblers is not a result of their impaired inhibition abilityKERTZMAN, Semion; LIDOGOSTER, Helena; AIZER, Anat et al.Psychiatry research (Print). 2011, Vol 188, Num 1, pp 71-77, issn 0165-1781, 7 p.Article

12-month follow-up study of drug treatment in pathological gamblers : A primary outcome studyDANNON, Pinhas N; LOWENGRUB, Katherine; MUSIN, Ernest et al.Journal of clinical psychopharmacology. 2007, Vol 27, Num 6, pp 620-624, issn 0271-0749, 5 p.Article